Tag:

Generics

Latest Headlines

Latest Headlines

German court deals another EU patent blow to Lilly's blockbuster Alimta

It's more bad news for Eli Lilly's Alimta in Europe. After losing a patent fight last year with Actavis in England, the Indianapolis drugmaker has now lost another in Germany, paving the way for knockoff versions of its top drug there.

India's Aurobindo Pharma eyes major earnings boost if U.S. FDA comes through on applications

SINGAPORE-- Aurobindo Pharma's U.S. unit, AuroMedics Pharma USA, says that if the U.S. FDA manages to speed up its approval process for generic drugs in the coming fiscal year, its earnings could shoot up by half.

Humira biosimilars will gut AbbVie's sales in 3 years, analyst says

Pharma analysts have different opinions on how much branded drugmakers will feel the heat from biosimilars--and when they'll feel it. But according to one Citi analyst, they're all underestimating the impact on AbbVie's top dog.

FDA puts off Mylan's Nexium generic, giving Teva's version free rein

Good news for Teva when it comes to Mylan's generic version of AstraZeneca's Nexium: It won't be around for a little while.

Drugmakers fall in line with Pakistani government's price-cutting plans

SINGAPORE-- Pakistan's pharmaceutical industry reportedly has decided to step aside and cease opposition to a government plan to force down the price of certain drugs marketed in the country as of July 1, 2016.

Merck hands over China joint venture to partner Simcere Pharma

SINGPAPORE-- Merck has confirmed it will move to let Simcere Pharmaceuticals run a high-profile China joint venture aimed at branded generic drugs announced in 2011 and focus instead on its mature products in the local market.

U.S. FDA plans to double drug inspectors in India as marketing applications soar

The U.S. FDA is hiring new inspectors in India to tackle the high rate of marketing applications made by local firms, an agency official said.

India jumps into the generic drug biz to compete with commercial players on price

SINGAPORE-- India's government is getting into the generic drug business. The state reportedly will launch its own brand, "Jan Aushadhi," on July 1, planning to sell up to 504 drugs on its "essential" list in direct competition with commercial drugmakers.

Ranbaxy-Sun U.S. approval hinges on selling antibacterial drug as FTC notes reach of Indian generic giant

Ranbaxy Laboratories may soon be selling its generic minocycline antibacterial drug to Torrent Pharmaceuticals as a condition for U.S. approval for its merger with Sun Pharmaceuticals.

Branded drug prices leapt almost 15% last year, led by pain pills, COPD and heart meds

It's no secret that branded drugmakers often rely on price hikes to keep U.S. sales growth coming, especially on older meds whose patents are close to the ends of their lives. But according to new data, prices spiked more than 10% last year--a trend that may fuel the payer backlash that's been steadily mounting.